Aerodiol versus the transdermal route: perspectives for patient preference.
about
Pharmacology of estrogens and progestogens: influence of different routes of administrationBisphosphonates in the management of postmenopausal osteoporosis--optimizing efficacy in clinical practice.Patient preference in the management of postmenopausal osteoporosis with bisphosphonates.Patients' and rheumatologists' preferences for the attributes of biological agents used in the treatment of rheumatic diseases in Spain.Comparison of efficacy and local tolerability of estradiol metered-dose transdermal spray to estradiol patch in a network meta-analysis.
P2860
Aerodiol versus the transdermal route: perspectives for patient preference.
description
2001 nî lūn-bûn
@nan
2001 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Aerodiol versus the transdermal route: perspectives for patient preference.
@ast
Aerodiol versus the transdermal route: perspectives for patient preference.
@en
type
label
Aerodiol versus the transdermal route: perspectives for patient preference.
@ast
Aerodiol versus the transdermal route: perspectives for patient preference.
@en
prefLabel
Aerodiol versus the transdermal route: perspectives for patient preference.
@ast
Aerodiol versus the transdermal route: perspectives for patient preference.
@en
P2093
P1433
P1476
Aerodiol versus the transdermal route: perspectives for patient preference.
@en
P2093
Fernandez-Villoria E
Marianowski L
Rozenberg S
P356
10.1016/S0378-5122(01)00202-X
P478
38 Suppl 1
P577
2001-06-01T00:00:00Z